The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Sims Mark E. | Chief Commercial Officer | Grant(A) | 285K | — | $0 |
| Jun 30, 2026 | Papa Joseph C | Director | Grant(A) | 1K | $8.64 | $11K |
| Jun 30, 2026 | Manning Paul B | Director | Grant(A) | 2K | $8.64 | $19K |
| Jun 30, 2026 | Loggia Nicoletta | Director | Grant(A) | 381 | $8.64 | $3K |
| Jun 29, 2026 | Barone Francesca | Chief Scientific Officer | Sell(S) | 23K | $10.06 | $236K |
| Jun 29, 2026 | Tyagarajan Seshu | Chief Technology Officer | Sell(S) | 7K | $10.02 | $70K |
| Jun 23, 2026 | Benz Edward J. JR | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Radhakrishnan Maha | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Martell Christopher | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Manning Paul B | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Gaeta Renee | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Nabel Gary J. | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Loggia Nicoletta | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Papa Joseph C | Director | Grant(A) | 32K | — | $0 |
| Jun 23, 2026 | Nguyen Diem | Director | Grant(A) | 32K | — | $0 |
| Mar 31, 2026 | Papa Joseph C | Director | Grant(A) | 3K | $4.11 | $11K |
| Mar 31, 2026 | Manning Paul B | Director | Grant(A) | 5K | $4.11 | $19K |
| Mar 31, 2026 | Loggia Nicoletta | Director | Grant(A) | 779 | $4.11 | $3K |
| Feb 23, 2026 | Manning Paul B | Director | Buy(P) | 550K | $5.45 | $3.0M |
| Jan 26, 2026 | Barone Francesca | Chief Scientific Officer | Grant(A) | 232K | — | $0 |
| Jan 26, 2026 | Tak Paul Peter | Chief Executive Officer, Director | Grant(A) | 629K | — | $0 |
| Jan 26, 2026 | Schoch Charles | Chief Financial Officer | Grant(A) | 232K | — | $0 |
| Jan 26, 2026 | Nichols William Garrett | Chief Medical Officer | Grant(A) | 137K | — | $0 |
| Jan 26, 2026 | Tyagarajan Seshu | Chief Technology Officer | Grant(A) | 154K | — | $0 |
| Jul 28, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 937 | $1.29 | $1K |
| Jul 28, 2025 | Nichols William Garrett | Chief Medical Officer | Sell(S) | 937 | $6.98 | $7K |
| Jul 28, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 937 | — | $0 |
| Jun 30, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 781 | $1.29 | $1K |
| Jun 30, 2025 | Nichols William Garrett | Chief Medical Officer | Sell(S) | 781 | $5.04 | $4K |
| Jun 30, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 781 | — | $0 |
| Jun 25, 2025 | Papa Joseph C | Director | Grant(A) | 64K | $4.67 | $300K |
| Jun 25, 2025 | Nabel Gary J. | Director | Grant(A) | 5K | $4.67 | $25K |
| Jun 25, 2025 | Schoch Charles | Chief Financial Officer | Grant(A) | 5K | $4.67 | $25K |
| Jun 25, 2025 | Barone Francesca | Chief Scientific Officer | Grant(A) | 4K | $4.67 | $20K |
| Jun 25, 2025 | Loggia Nicoletta | Director | Grant(A) | 2K | $4.67 | $10K |
| Jun 25, 2025 | Martell Christopher | Director | Grant(A) | 111K | $4.67 | $520K |
| Jun 25, 2025 | Manning Paul B | Director | Grant(A) | 1.1M | $4.67 | $5.0M |
| Jun 25, 2025 | Tak Paul Peter | Chief Executive Officer, Director | Grant(A) | 43K | $4.67 | $200K |
| Jun 25, 2025 | Tyagarajan Seshu | Chief Technology Officer | Grant(A) | 5K | $4.67 | $25K |
| Jun 20, 2025 | Schoch Charles | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Jun 17, 2025 | Papa Joseph C | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2025 | Nguyen Diem | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2025 | Nabel Gary J. | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2025 | Martell Christopher | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2025 | Manning Paul B | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2025 | Loggia Nicoletta | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2025 | Gaeta Renee | Director | Grant(A) | 14K | — | $0 |
| Jun 17, 2025 | Benz Edward J. JR | Director | Grant(A) | 14K | — | $0 |
| Jun 4, 2025 | Radhakrishnan Maha | Director | Grant(A) | 28K | — | $0 |
| Mar 19, 2025 | Tak Paul Peter | Chief Executive Officer, Director | Sell(S) | 400 | $9.00 | $4K |
| Mar 18, 2025 | Tak Paul Peter | Chief Executive Officer, Director | Sell(S) | 26K | $8.77 | $226K |
| Mar 18, 2025 | Barone Francesca | Chief Scientific Officer | Option exercise(M) | 18K | $1.55 | $28K |
| Mar 18, 2025 | Barone Francesca | Chief Scientific Officer | Sell(S) | 32K | $8.76 | $282K |
| Mar 18, 2025 | Barone Francesca | Chief Scientific Officer | Option exercise(M) | 18K | — | $0 |
| Mar 18, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 5K | $3.75 | $17K |
| Mar 18, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 14K | $1.29 | $18K |
| Mar 18, 2025 | Nichols William Garrett | Chief Medical Officer | Sell(S) | 45K | $8.76 | $397K |
| Mar 18, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Mar 18, 2025 | Nichols William Garrett | Chief Medical Officer | Option exercise(M) | 14K | — | $0 |
| Mar 17, 2025 | Schoch Charles | See Remarks | Sell(S) | 5K | $8.83 | $44K |
| Mar 17, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell(S) | 31K | $8.82 | $276K |
| Mar 17, 2025 | Tyagarajan Seshu | Chief Technology Officer | Option exercise(M) | 20K | $1.29 | $26K |
| Mar 17, 2025 | Tyagarajan Seshu | Chief Technology Officer | Option exercise(M) | 20K | — | $0 |
| Feb 21, 2025 | Aguilar-Cordova Estuardo | 10% Owner | Disposed to issuer(D) | 11K | $12.02 | $127K |
| Feb 21, 2025 | Aguilar-Cordova Estuardo | 10% Owner | Disposed to issuer(D) | 11K | $12.02 | $127K |
| Feb 12, 2025 | Barone Francesca | Chief Scientific Officer | Grant(A) | 115K | — | $0 |
| Feb 12, 2025 | Tak Paul Peter | Chief Executive Officer, Director | Grant(A) | 525K | — | $0 |
| Feb 12, 2025 | Nichols William Garrett | Chief Medical Officer | Grant(A) | 107K | — | $0 |
| Feb 12, 2025 | Schoch Charles | See Remarks | Grant(A) | 83K | — | $0 |
| Feb 12, 2025 | Tyagarajan Seshu | Chief Technology Officer | Grant(A) | 65K | — | $0 |
| Feb 10, 2025 | Aguilar-Cordova Estuardo | 10% Owner | Disposed to issuer(D) | 31K | $8.61 | $270K |
| Jan 15, 2025 | Nichols William Garrett | Chief Medical Officer | Sell(S) | 10K | $7.23 | $75K |
| Jan 15, 2025 | Tak Paul Peter | Chief Executive Officer, Director | Sell(S) | 22K | $7.23 | $157K |
| Jan 15, 2025 | Schoch Charles | See Remarks | Sell(S) | 10K | $7.23 | $69K |
| Jan 15, 2025 | Barone Francesca | Chief Scientific Officer | Sell(S) | 14K | $7.23 | $98K |
| Jan 15, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell(S) | 14K | $7.23 | $104K |
| Jan 8, 2025 | Nichols William Garrett | Chief Medical Officer | Sell(S) | 11K | $8.22 | $89K |
| Jan 8, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell(S) | 15K | $8.22 | $120K |
| Jan 8, 2025 | Tak Paul Peter | Chief Executive Officer, Director | Sell(S) | 21K | $8.22 | $174K |
| Jan 8, 2025 | Schoch Charles | See Remarks | Sell(S) | 10K | $8.22 | $82K |
| Jan 8, 2025 | Barone Francesca | Chief Scientific Officer | Sell(S) | 14K | $8.22 | $112K |
| Dec 27, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $8.85 | $443K |
| Dec 27, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $8.85 | $443K |
| Dec 26, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $9.01 | $451K |
| Dec 26, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $9.01 | $451K |
| Dec 24, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $8.82 | $441K |
| Dec 24, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $8.82 | $441K |
| Dec 23, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $8.52 | $426K |
| Dec 23, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 50K | $8.52 | $426K |
| Dec 20, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 100K | $9.00 | $900K |
| Dec 20, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 100K | $9.00 | $900K |
| Dec 16, 2024 | Manning Paul B | Director | Buy(P) | 500K | $6.00 | $3.0M |
| Dec 16, 2024 | Manning Paul B | Director | Buy(P) | 750K | $6.00 | $4.5M |
| Dec 12, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Disposed to issuer(D) | 200K | $10.04 | $2.0M |
| Dec 12, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Disposed to issuer(D) | 200K | $10.04 | $2.0M |
| Dec 11, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Disposed to issuer(D) | 200K | $8.53 | $1.7M |
| Dec 11, 2024 | Aguilar-Cordova Estuardo | 10% Owner | Disposed to issuer(D) | 200K | $8.53 | $1.7M |
| Dec 6, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 20K | $5.23 | $105K |
| Dec 5, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 20K | $4.79 | $96K |
| Dec 4, 2024 | Aguilar Laura K. | 10% Owner | Disposed to issuer(D) | 20K | $4.46 | $89K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).